TMLEP Clinical Updates
TMLEP’s Clinical Updates are provided in order to raise awareness of clinical risk issues and to reduce incidence recurrence and improve patient safety. Facts have been anonymised to maintain data confidentiality, however learning points remain applicable.
To receive notifications as soon as new updates become available, please enter your details in the form below or follow TMLEP’s Twitter or LinkedIn feeds (accessible at the top of the page).
-
The Importance of Distinguishing Between the Symptoms of Cervical Myelopathy and Sciatica
24 November 2020Cervical myelopathy is compression on the cervical spinal cord and can cause a variety of signs and symptoms which are typically attributed to other conditions.
-
The Importance of acting on abnormal ECG Results in relation to Cardiac Infarction
17 November 2020Cardiac Infarction is injury of the heart muscle caused by a lack of blood supply. Abnormal ECG findings should be acted on, leading to further investigations, such as baseline tests and referral to the appropriate medical expert, in order to prevent some of the potential long-term consequences of Cardiac Infarction.
-
The Importance of Identifying GA1
10 November 2020GA1 is an inherited metabolic disorder resulting from a deficiency of the enzyme glutaryl-CoA dehydrogenase and is genetically determined. Diagnosis of GA1 is imperative, so as to ensure that a carefully-controlled diet is implemented, in order to prevent brain damage from occurring.
-
The Risks of Complications Regarding CVP Lines
03 November 2020This article covers the risks of complications regarding Central venous pressure (CVP) lines. CVP lines are used to monitor central venous blood pressure. It is important that the risks and complications of CVP line insertion are explained to the patient to ensure they are correctly consented under Montgomery v Lanarkshire Health Board [2015] UKSC 11.